Literature DB >> 19774394

Mycoplasma pneumoniae associated opsoclonus-myoclonus syndrome in three cases.

Benedikt Maria Huber1, Susi Strozzi, Maja Steinlin, Christoph Aebi, Simon Fluri.   

Abstract

Opsoclonus-myoclonus syndrome (OMS) is a rare acquired movement disorder occurring in all age groups, predominantly in infants. Although the exact pathogenesis is still undefined, there is strong evidence for a paraneoplastic or parainfectious immune process resulting in central nervous system dysfunction. Mycoplasma pneumoniae has been implicated in a number of immune-mediated neurologic diseases [28]. However, the association of M. pneumoniae and opsoclonus-myoclonus-ataxia syndrome is not well established so far. We present three cases with opsoclonus-myoclonus-ataxia syndrome in adolescents following an infection with M. pneumoniae. Monophasic disease course and full recovery correspond to the favorable prognosis known from parainfectious cases in young adults. This should affect therapeutic consideration. OMS should be added to the spectrum of M. pneumoniae-associated neurologic complications. Nevertheless, neuroblastoma has to be ruled out in all cases of OMS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19774394     DOI: 10.1007/s00431-009-1048-3

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  26 in total

Review 1.  An update on opsoclonus.

Authors:  Agnes Wong
Journal:  Curr Opin Neurol       Date:  2007-02       Impact factor: 5.710

2.  Serum autoantibodies in childhood opsoclonus-myoclonus syndrome: an analysis of antigenic targets in neural tissues.

Authors:  A M Connolly; A Pestronk; S Mehta; M R Pranzatelli; M J Noetzel
Journal:  J Pediatr       Date:  1997-06       Impact factor: 4.406

3.  Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus.

Authors:  L Bataller; F Graus; A Saiz; J J Vilchez
Journal:  Brain       Date:  2001-02       Impact factor: 13.501

Review 4.  Mycoplasma pneumoniae central nervous system infections.

Authors:  Florian Daxboeck
Journal:  Curr Opin Neurol       Date:  2006-08       Impact factor: 5.710

Review 5.  Laboratory diagnosis of Mycoplasma pneumoniae infection.

Authors:  F Daxboeck; R Krause; C Wenisch
Journal:  Clin Microbiol Infect       Date:  2003-04       Impact factor: 8.067

6.  Autoantigen diversity in the opsoclonus-myoclonus syndrome.

Authors:  Luis Bataller; Myrna R Rosenfeld; Francesc Graus; Juan J Vilchez; Nai-Kong V Cheung; Josep Dalmau
Journal:  Ann Neurol       Date:  2003-03       Impact factor: 10.422

7.  Neuroepidemiologic trends in 105 US cases of pediatric opsoclonus-myoclonus syndrome.

Authors:  Elizabeth D Tate; Tyler J Allison; Michael R Pranzatelli; Steven J Verhulst
Journal:  J Pediatr Oncol Nurs       Date:  2005 Jan-Feb       Impact factor: 1.636

Review 8.  Mycoplasma pneumoniae and its role as a human pathogen.

Authors:  Ken B Waites; Deborah F Talkington
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

Review 9.  Mycoplasma pneumoniae: nervous system complications in childhood and review of the literature.

Authors:  Uluç Yiş; Semra Hiz Kurul; Handan Cakmakçi; Eray Dirik
Journal:  Eur J Pediatr       Date:  2008-05-28       Impact factor: 3.183

10.  Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in the pediatric opsoclonus-myoclonus syndrome.

Authors:  M R Pranzatelli; Y Huang; E Tate; M Stanley; M J Noetzel; S M Gospe; K Banasiak
Journal:  Ann Neurol       Date:  1995-02       Impact factor: 10.422

View more
  10 in total

1.  Correspondence: A further case of opsoclonus-myoclonus syndrome associated with Mycoplasma pneumoniae infection.

Authors:  Takashi Shiihara; Yukitoshi Takahashi
Journal:  Eur J Pediatr       Date:  2009-11-27       Impact factor: 3.183

Review 2.  Autoimmune Movement Disorders: a Clinical and Laboratory Approach.

Authors:  Josephe Archie Honorat; Andrew McKeon
Journal:  Curr Neurol Neurosci Rep       Date:  2017-01       Impact factor: 5.081

3.  Commentary.

Authors:  Victoria Bîrluţiu
Journal:  J Neurosci Rural Pract       Date:  2014-11

Review 4.  Classification of Extrapulmonary Manifestations Due to Mycoplasma pneumoniae Infection on the Basis of Possible Pathogenesis.

Authors:  Mitsuo Narita
Journal:  Front Microbiol       Date:  2016-01-28       Impact factor: 5.640

5.  Adult-onset opsoclonus-myoclonus-ataxia syndrome as a manifestation of brazilian lyme disease-like syndrome: a case report and review of literature.

Authors:  Angelina Maria Martins Lino; Raphael Ribeiro Spera; Fernando Peixoto Ferraz de Campos; Christian Henrique de Andrade Freitas; Márcio Ricardo Taveira Garcia; Leonardo da Costa Lopes; Aleksander Snioka Prokopowitsch
Journal:  Autops Case Rep       Date:  2014-03-31

6.  Central Nervous System Vasculitis as a Rare Presentation of Mycoplasma pneumoniae: A Case Report.

Authors:  Ashraf Omer Elamin Ahmed; Mona Mohammad Ibraheem Babikir; Amir Elssoni Mahjoup Khojali; Suresh Nalaka Menik Arachchige; Abdirahman Mohamud Abdirahman; Mouhand Faisal Hamad Mohamed
Journal:  Case Rep Neurol       Date:  2020-11-09

Review 7.  Update on opsoclonus-myoclonus syndrome in adults.

Authors:  Sun-Young Oh; Ji-Soo Kim; Marianne Dieterich
Journal:  J Neurol       Date:  2018-11-27       Impact factor: 4.849

8.  Opsoclonus-myoclonus syndrome attributable to West Nile encephalitis: a case report.

Authors:  Victoria Bîrluţiu; Rareş Mircea Bîrluţiu
Journal:  J Med Case Rep       Date:  2014-06-26

9.  Movement disorders of probable infectious origin.

Authors:  Ketan Jhunjhunwala; M Netravathi; Pramod Kumar Pal
Journal:  Ann Indian Acad Neurol       Date:  2014-07       Impact factor: 1.383

Review 10.  Myoclonus and cerebellar ataxia associated with COVID-19: a case report and systematic review.

Authors:  Jason L Chan; Keely A Murphy; Justyna R Sarna
Journal:  J Neurol       Date:  2021-02-22       Impact factor: 4.849

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.